A biomarker of myocardial fibrosis predicts long-term response to cardiac resynchronization therapy

被引：16

作者：

Garcia-Bolao, Ignacio

Macias, Alfonso

Lopez, Begona

Gonzalez, Arantxa

Gavira, Juan J.

Azcarate, Pedro

Alegría, Eduardo

Díez, Javier

机构：

[1] Univ Navarra, Area Ciencias Cardiovasc, CIMA, E-31080 Pamplona, Spain

[2] Univ Navarra, Univ Clin, E-31080 Pamplona, Spain

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 11期

关键词：

D O I：

10.1016/j.jacc.2006.03.012

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：2335 / 2337

页数：3

共 3 条

[1]

The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease [J].

López, B ;

González, A ;

Querejeta, R ;

Díez, J .

JOURNAL OF HYPERTENSION, 2005, 23 (08) :1445-1451

[2]

Effects of loor diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure [J].

López, B ;

Querejeta, R ;

González, A ;

Sánchez, E ;

Larman, M ;

Díez, J .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (11) :2028-2035

[3]

Increased collagen type I synthesis in patients with heart failure of hypertensive origin -: Relation to myocardial fibrosis [J].

Querejeta, R ;

López, B ;

González, A ;

Sánchez, E ;

Larman, M ;

Ubago, JLM ;

Díez, J .

CIRCULATION, 2004, 110 (10) :1263-1268

← 1 →